galactose has been researched along with alpha-Galactosidase A Deficiency in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (27.78) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 4 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Arévalo-Gómez, A; Besada, P; Fernández-Martín, J; Gallardo-Gómez, M; Ortolano, S; Pantano, S; Patiño-Álvarez, L; Pérez-Márquez, T; Ruz-Zafra, A; Silva-López, C; Terán, C | 1 |
| Anisha, GS | 1 |
| Charoenwongpaiboon, T; Klaewkla, M; Prousoontorn, J | 1 |
| Allocca, M; Andreotti, G; Cubellis, MV; Hay Mele, B; Liguori, L; Lukas, J; Monti, MC; Monticelli, M; Morretta, E | 1 |
| Asfaw, B; Dobrovolný, R; Havlícek, V; Hulková, H; Kuchar, L; Ledvinová, J; Rybová, J; Sikora, J; Škultéty, L | 1 |
| Suzuki, Y | 1 |
| Clark, NE; Garman, SC; Guce, AI; Rogich, JJ | 1 |
| Beck, M; Dietz, R; Kampmann, C; Osterziel, KJ; Perrot, A; Wiethoff, CM | 1 |
| Kolter, T; Wendeler, M | 1 |
| Ishii, S; Kamei, S; Kase, R; Okumiya, T; Sakuraba, H; Suzuki, Y; Takenaka, T | 1 |
| Ishii, S; Kase, R; Sakuraba, H; Suzuki, Y | 1 |
| Chimenti, C; Desnick, RJ; Eng, CM; Frustaci, A; Natale, L; Pieroni, M; Ricci, R; Russo, MA | 1 |
| Gahl, WA | 1 |
| Douste-Blazy, L; Maret, A; Negre, A; Salvayre, R | 1 |
| Mapes, CA; Sweeley, CC | 1 |
| Borst, P; Hamers, MN; Molenaar, JL; Rietra, PJ; Tager, JM | 1 |
| Philippart, M | 1 |
| Brady, RO | 1 |
6 review(s) available for galactose and alpha-Galactosidase A Deficiency
| Article | Year |
|---|---|
Biopharmaceutical applications of α-galactosidases.
Topics: alpha-Galactosidase; Biological Products; Fabry Disease; Galactose; Galactosidases; Humans | 2023 |
[The world of galactose and glucose: pathogenesis and therapy of lysosomal diseases].
Topics: Administration, Oral; Animals; Fabry Disease; Galactose; Galactosidases; Gangliosidosis, GM1; Glucose; Glucosidases; Humans; Leukodystrophy, Globoid Cell; Lysosomal Storage Diseases; Molecular Chaperones; Molecular Targeted Therapy; Pathology, Molecular; Proteostasis Deficiencies | 2014 |
The heart in Anderson Fabry disease.
Topics: Adult; alpha-Galactosidase; Animals; Arrhythmias, Cardiac; Biopsy; Cardiomyopathy, Hypertrophic; Cell Line; Child; Clinical Trials as Topic; Coronary Disease; Cricetinae; Diagnosis, Differential; Echocardiography; Electrocardiography; Endocardium; Enzyme Therapy; Fabry Disease; Female; Galactose; Heart Diseases; Heart Failure; Heart Valve Diseases; Humans; Hypertrophy, Left Ventricular; Incidence; Infant, Newborn; Infusions, Intravenous; Isoenzymes; Magnetic Resonance Imaging; Male; Middle Aged; Mitral Valve Prolapse; Myocardium; Sex Factors; Smoking | 2002 |
Chemical chaperones--a new concept in drug research.
Topics: 1-Deoxynojirimycin; alpha-Galactosidase; Animals; Enzyme Stability; Fabry Disease; Galactose; Gaucher Disease; Glycoside Hydrolases; Humans; Imino Sugars; Molecular Weight; Piperidines; Protein Conformation; Protein Folding | 2003 |
Fabry disease: kidney transplantation as an enzyme replacement technic.
Topics: Ceramides; Enzyme Therapy; Enzymes; Fabry Disease; Galactose; Glycolipids; Humans; Hydrogen-Ion Concentration; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Lysosomes; Male; Splenectomy; Transplantation, Homologous | 1973 |
Disorders of lipid metabolism.
Topics: Adult; Animals; Bone Marrow; Cell Line; Ceramides; Child; Fabry Disease; Fucose; Galactose; Gangliosides; Gaucher Disease; Genetic Variation; Glycolipids; Glycoside Hydrolases; Humans; Leukemia, Myeloid; Leukodystrophy, Globoid Cell; Leukodystrophy, Metachromatic; Lipid Metabolism, Inborn Errors; Lipidoses; Mice; Niemann-Pick Diseases; Sulfoglycosphingolipids | 1972 |
12 other study(ies) available for galactose and alpha-Galactosidase A Deficiency
| Article | Year |
|---|---|
The New Pharmacological Chaperones PBXs Increase α-Galactosidase A Activity in Fabry Disease Cellular Models.
Topics: 1-Deoxynojirimycin; alpha-Galactosidase; Drug Stability; Enzyme Replacement Therapy; Fabry Disease; Galactose; HEK293 Cells; Humans; Hydrogen-Ion Concentration; Leukocytes, Mononuclear; Models, Biological; Models, Molecular; Mutation; Protein Conformation | 2021 |
A theoretical study on binding and stabilization of galactose and novel galactose analogues to the human α-galactosidase A variant causing Fabry disease.
Topics: alpha-Galactosidase; Fabry Disease; Galactose; Humans; Models, Theoretical; Mutation | 2023 |
Curcumin Has Beneficial Effects on Lysosomal Alpha-Galactosidase: Potential Implications for the Cure of Fabry Disease.
Topics: 1-Deoxynojirimycin; alpha-Galactosidase; Curcumin; Fabry Disease; Galactose; Humans; Lysosomes; Mutation | 2023 |
Specific storage of glycoconjugates with terminal α-galactosyl moieties in the exocrine pancreas of Fabry disease patients with blood group B.
Topics: ABO Blood-Group System; Acinar Cells; Case-Control Studies; Fabry Disease; Galactose; Glycosphingolipids; Humans; Insulin-Secreting Cells; Male; Middle Aged; Pancreas | 2018 |
The molecular basis of pharmacological chaperoning in human α-galactosidase.
Topics: 1-Deoxynojirimycin; alpha-Galactosidase; Binding Sites; Crystallography, X-Ray; Fabry Disease; Galactose; Humans; Hydrogen-Ion Concentration; Mutagenesis, Site-Directed; Phase Transition; Protein Structure, Tertiary; Protein Unfolding; Transition Temperature | 2011 |
Galactose stabilizes various missense mutants of alpha-galactosidase in Fabry disease.
Topics: alpha-Galactosidase; Amino Acid Sequence; Animals; Cell Line; Chlorocebus aethiops; Codon; Exons; Fabry Disease; Galactose; Humans; Kidney; Kinetics; Lymphocytes; Point Mutation; Recombinant Proteins; Transfection | 1995 |
Characterization of a mutant alpha-galactosidase gene product for the late-onset cardiac form of Fabry disease.
Topics: Age of Onset; alpha-Galactosidase; Amino Acid Sequence; Animals; Cell Line; Enzyme Stability; Fabry Disease; Galactose; Gene Expression; Genetic Variation; Glutamates; Glutamic Acid; Glutamine; Humans; Hydrogen-Ion Concentration; Kinetics; Lymphocytes; Melibiose; Point Mutation; Recombinant Proteins; Thermodynamics; Transfection | 1993 |
Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy.
Topics: alpha-Galactosidase; Cardiac Output; Cardiomyopathy, Hypertrophic; Echocardiography; Fabry Disease; Galactose; Heart; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Microscopy, Electron; Middle Aged; Molecular Chaperones; Mutation, Missense; Myocardium | 2001 |
New therapies for Fabry's disease.
Topics: alpha-Galactosidase; Fabry Disease; Galactose; Humans; Trihexosylceramides | 2001 |
[Neutral glycosphingolipids of Fabry's disease lymphoblastoid lines established by Epstein-Barr virus transformation].
Topics: Adult; Autoradiography; B-Lymphocytes; Cell Line; Cell Transformation, Viral; Chemical Phenomena; Chemistry; Fabry Disease; Fetal Blood; Galactose; Glucose; Glycosphingolipids; Herpesvirus 4, Human; Humans; Hydrogen-Ion Concentration; Infant, Newborn; Kinetics | 1985 |
Galactosyl (alpha 1--4)galactosylceramide: galactosyl hydrolase activity in normal and Fabry plasma.
Topics: Blood Protein Electrophoresis; Blood Proteins; Cerebrosides; Chromatography, Affinity; Fabry Disease; Galactose; Galactosidases; Glycoside Hydrolases; Humans; Hydrogen-Ion Concentration; Isoelectric Focusing | 1973 |
Investigation of the alpha-galactosidase deficiency in Fabry's disease using antibodies against the purified enzyme.
Topics: Animals; Antibodies; Antibody Formation; Chemical Precipitation; Chromatography; Chromatography, Gel; Cross Reactions; Dialysis; Fabry Disease; Galactose; Galactosidases; Glycosides; Humans; Immune Tolerance; Immunoassay; Immunodiffusion; Immunoelectrophoresis; Isoenzymes; Kidney; Lipid Metabolism, Inborn Errors; Male; Nitrophenols; Rabbits; Ultrafiltration | 1974 |